COVID-19 as a cause of death fell from the #4 spot in 2022 to #10 in 2023, which may account for some of the overall decline in the US mortality rate, suggest CDC experts.
All News

The Advisory Committee on Immunization Practices' revisions prioritize vulnerable older adults and those at higher risk of severe infection.

In a new study of older adults who underwent cancer surgery, those who visited their PCP within 90 days had a significantly lower postoperative mortality rate.

Your daily dose of the clinical news you may have missed.

This summary of updates to the ACIP 2024 Adult Vaccination recommendations includes 4 new vaccines and new formulations for COVID-19 and influenza shots.

The Shield blood test is approved for primary CRC screening in adults 45 years and older at average risk for the disease.

Your daily dose of the clinical news you may have missed.

Your daily dose of the clinical news you may have missed.

Finerenone treatment achieved a statistically significant reduction in a composite endpoint of CV death and HF events in a population not limited to CKD in T2D, Bayer announced.

New study findings suggest that in older adults stable HbA1c within individualized target ranges over time may help reduce risk of Alzheimer disease and other dementias.

Semaglutide bought online without a prescription were unregistered, contaminated, and had levels of product that exceeded labeled amount, according to new data.

Your daily dose of the clinical news you may have missed.

The lecanemab Clarity AD open label extension study returned no new safety signals and data reflect the therapy's disease modifying effects on key biomarkers.

Your daily dose of the clinical news you may have missed.

HPV series initiation and completion was lower among adolescents seen at public vs private care settings and so was clinician guidance on vaccination in a new study.

Three out of 5 US youths who died by suicide between 2010 and 2021 did not have a documented preceding mental health diagnosis, researchers reported.

Your daily dose of the clinical news you may have missed.

Tirzepatide reduced the risk of severe heart failure outcomes by 38% and drove weight loss of 15.7% in adults with HFpEF and obesity, with and without T2D..

Your daily dose of the clinical news you may have missed.

